SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Humanm Antibodys:ABGX,MEDX, CAT , Morphosys....
An SI Board Since January 2000
Posts SubjectMarks Bans
23 11 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
A hot subject already for some time. Discussions on each company's pro's and ante's are going on, but widespread over individual boards. At a particular board for an individual company are opponent opinions in general not appreciated.

Need for this? A widely open board for more general discussions, without becoming agressive if there are opponents?

Martin
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23Martin, your thread idea is a good one for discussing developments in the field.LAWRENCE C.-6/26/2001
22Friday May 25, 4:00 pm Eastern Time Press Release SOURCE: Medarex, Inc. Medarebetone-5/25/2001
21doubletwist.comkeokalani'nui-9/18/2000
20Any comments on the IMGN ABGX deal? TIA Long IMGN TI2TI2, TechInvestorToo-9/8/2000
19 Martin, didn't realise you'd started this thread (I set up another onenigel bates-6/1/2000
18 Development can make for Powerful Drugs San Jose Mercury News www7.mercurycentJongmans-3/30/2000
17 Rockefeller University researchers discover immun-cell mechanism that boosts thJongmans-3/29/2000
16 MEDX in a new collaboration w REGN: Medarex, Regeneron to co-develop, market nMel Spivak-3/10/2000
15 Comparing market valuations again, the conclusion is still: Europeans CambridgeJongmans-3/5/2000
14 Market valuations hMAbs companies compared... Abgenix......................US$Jongmans-2/22/2000
13 Monoclonal Antibodies:A 25 year RollerCoaster Ride.. Interesting Article "Jongmans-2/21/2000
12 MorphoSys AG and GPC AG announce milestone in search for new cancer therapy moJongmans-2/14/2000
11 Cambridge Antibody Technology up (=2%) and MorphoSys(+37%) strongly up today mJongmans-2/14/2000
10 Better Mice Make Better Monoclonals biospace.com Regarding CAT: patent positiJongmans-2/9/2000
9 CAT: Annual General Meeting Statement biz.yahoo.com martinJongmans-2/4/2000
8 CAT: D2E7 Becomes the First Human Monoclonal Antibody into Phase lll Clinical TJongmans-2/4/2000
7 Human Genome Sciences expands antibody programs previously announced with AbgenJongmans-2/2/2000
6 Cambridge Antibody up 24,6 % today at Pst 14,05!!??? MartinJongmans-1/31/2000
5 Cambridge Antibody Technology and MorphoSys continue their strong uptrend. marJongmans-1/26/2000
4 MEDX @ 71 New Dain Raucher Analyst Report -Target 106 Dain Rauscher by: TheczMel Spivak-1/24/2000
3 Cambridge Antibody Continues its rise. This morning + 13% Quotes: moneyworld.cJongmans-1/24/2000
2 I think Morphosys is a great company. I own the stock and will add more next weWolfgang-1/22/2000
1 Websites: Abgenix: abgenix.com Medarex: medarex.com Cambridge Antibody TechnJongmans-1/22/2000
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News